NCT06281041View on ClinicalTrials.gov

Nationwide Cohort Study of Antiplatelet Agents as Primary Prevention

CompletedOBSERVATIONAL
Enrollment

4,657

Participants

Timeline

Start Date

January 1, 2013

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Coronary Artery DiseaseCoronary Artery Stenosis
Interventions
DRUG

Antiplatelet Agents

Aspirin or clopidogrel

Trial Locations (1)

Unknown

Chonnam National University Medical School, Gwangju

All Listed Sponsors
collaborator

Chonnam National University

OTHER

lead

Samsung Medical Center

OTHER

NCT06281041 - Nationwide Cohort Study of Antiplatelet Agents as Primary Prevention | Biotech Hunter | Biotech Hunter